Glycomet GP 0.5 Tablet SR is a prescription medicine that is available as a Tablet. It is primarily used for the treatment of Diabetes. Other than this, Glycomet GP 0.5 Tablet SR has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Glycomet GP 0.5 Tablet SR depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
The side effects typically associated with Glycomet GP 0.5 Tablet SR include Headache, Nausea or vomiting, Dizziness. Some other side effects of Glycomet GP 0.5 Tablet SR have been listed ahead. Usually, these side effects of Glycomet GP 0.5 Tablet SR go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Glycomet GP 0.5 Tablet SR is Unknown for pregnant women and Safe for women who are breastfeeding. Warnings related to Glycomet GP 0.5 Tablet SR's effects on the liver, heart and kidney, if any, have been listed below.
Glycomet GP 0.5 Tablet SR can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Glycomet GP 0.5 Tablet SR in conditions like Heart Disease, Kidney Disease, Liver Disease. The section on Glycomet GP 0.5 Tablet SR contraindications lists all such conditions.
Drug interactions for Glycomet GP 0.5 Tablet SR have been reported in the medical literature. A complete list of these interactions is given below.
You should also be aware that Glycomet GP 0.5 Tablet SR is not safe while driving, and is not addiction.
Glycomet GP 0.5 Tablet SR is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Glycomet GP 0.5 Tablet SR safe for pregnant women?
No research has been done to ascertain the safety of Glycomet GP in pregnant women. If you are pregnant, it is best to ask a doctor to know if you can take it.
Is the use of Glycomet GP 0.5 Tablet SR safe during breastfeeding?
Glycomet GP does not show any side effects in breastfeeding women.
What is the effect of Glycomet GP 0.5 Tablet SR on the Kidneys?
Kidney can be affected by Glycomet GP. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Glycomet GP 0.5 Tablet SR on the Liver?
Glycomet GP can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Glycomet GP 0.5 Tablet SR on the Heart?
Glycomet GP has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Glycomet GP 0.5 Tablet SR unless your doctor advises you to do so -
Is this Glycomet GP 0.5 Tablet SR habit forming or addictive?
Glycomet GP 0.5 Tablet SR does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Glycomet GP 0.5 Tablet SR. So it is best to avoid driving.
Is it safe?
Glycomet GP 0.5 Tablet SR is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Glycomet GP 0.5 Tablet SR cannot treat any kind of mental disorder.
Interaction between Food and Glycomet GP 0.5 Tablet SR
Information is not available on the interaction of any foods with Glycomet GP 0.5 Tablet SR, due to a lack of research on this.
Interaction between Alcohol and Glycomet GP 0.5 Tablet SR
Due to lack of research, there is no information about the side effects of taking Glycomet GP 0.5 Tablet SR with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826